Topisal - 3% Lotion is a combination of two medicines: Clobetasol Topical and Salicylic Acid which treat eczema and psoriasis. Clobetasol Topical is a steroid medicine. It blocks the production of certain chemical messengers (prostaglandins) that make the skin red, swollen and itchy. Salicylic Acid is a keratolytic medicine which breaks down keratin clumps, removes dead skin cells and softens the skin. It also enhances the absorption of Clobetasol Topical into the skin.
Topisal - 3% Lotion may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Topisal - 3% Lotion is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Topisal - 3% Lotion does not usually affect your ability to drive.
Topisal - 3% Lotion is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Topisal - 3% Lotion may not be needed in these patients. Please consult your doctor.
Topisal - 3% Lotion is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Topisal - 3% Lotion may not be needed in these patients. Please consult your doctor.
What were the side-effects while using Topisal - 3% Lotion?
No Side Effect
Application site irritation
How do you take Topisal Lotion?
With or without food
How much was the improvement?
Please rate Topisal - 3% Lotion on price
What are you using Topisal Lotion for?
Keratoses (Abnormal skin growth)
Survey Participants: 29
“The following are the results of on-going survey on 1mg.com for Topisal - 3% Lotion. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 28th Jun 2017.